« Return to News | CROs/Service Providers

PPD Reports Big Drop in Q1 Earnings, Opens Chinese Vaccine Facility

Tuesday, April 27, 2010 06:29 AM

Wilmington, N.C-based contract research organization (CRO) PPD reported first quarter 2010 earnings late yesterday along with the opening of a vaccine clinical research center in Taizhou, China.

Through the new research center, located at the Taizhou China Medical City, PPD will provide clinical monitoring services to companies developing vaccines in China.

PPD’s first quarter 2010 net revenues were down almost $20 million from the first quarter 2009 to $346.8 million, compared to net revenue of $364.4 million in Q1 2009. First quarter 2010 income from operations was $26.1 million, a significant drop from 2009 first quarter income of $66.6 million. Earnings per share for the quarter were $0.14, compared with $0.38 for the same period last year.

PPD attributed the decrease in earnings to lower net revenue and increased expenses related to the company’s recent acquisitions and the planned spin-off of the company’s compound partnering business.

"During the first quarter, request for proposal activity improved, cancellations and adjustments decreased to a normal level, and we continued to make strategic investments to strengthen our business models and global infrastructure. Our leadership team is fully-aligned, and we are committed to pursuing our strategic initiatives to create long-term value for our shareholders," said David Grange, PPD CEO.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.